Advertisement |  | Your one-stop shop for Next Generation Sequencing
Introducing the only available complete solution for NGS:
- DNA shearing: Shear DNA anywhere from 150kb to 75kb reliably
- Library preparation kits: Down to 50pg of input!
- Library prep automation: Unique, walk-away, hands-free, superb reproducibility
Learn more |  | | |  |  |
TABLE OF CONTENTS
|  |  |  | Volume 33, Issue 34 (August 2014) |  | In this issue Review Original Articles Short Communications
Also new    AOP | |  |  |  | Advertisement |  | 
With scientific editing from MSC you benefit from Nature-standard editing and advice on your manuscript, giving you the best chance of acceptance by the journal of your choice. Expert editors, fast service.
Submit your manuscript today and save 10% with code SE_TOC14! | | | |  |  | Review | Top |  | Post-translational modifications and the Warburg effectT Hitosugi and J Chen Oncogene 2014 33: 4279-4285; advance online publication, October 7, 2013; 10.1038/onc.2013.406 Abstract | Full Text |  | Original Articles | Top |  | Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesisS Cagnet, M M Faraldo, M Kreft, A Sonnenberg, K Raymond and M A Glukhova Oncogene 2014 33: 4286-4295; advance online publication, September 30, 2013; 10.1038/onc.2013.391 Abstract | Full Text |  |  |  | miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasisX Fu, Z Meng, W Liang, Y Tian, X Wang, W Han, G Lou, X Wang, F Lou, Y Yen, H Yu, R Jove and W Huang Oncogene 2014 33: 4296-4306; advance online publication, September 23, 2013; 10.1038/onc.2013.385 Abstract | Full Text |  |  |  | miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancerL Du, Z Zhao, X Ma, T-H Hsiao, Y Chen, E Young, M Suraokar, I Wistuba, J D Minna and A Pertsemlidis Oncogene 2014 33: 4307-4315; advance online publication, September 16, 2013; 10.1038/onc.2013.381 Abstract | Full Text |  |  |  | SUMOylation inhibits FOXM1 activity and delays mitotic transition OPENS S Myatt, M Kongsema, C W-Y Man, D J Kelly, A R Gomes, P Khongkow, U Karunarathna, S Zona, J K Langer, C W Dunsby, R C Coombes, P M French, J J Brosens and E W-F Lam Oncogene 2014 33: 4316-4329; advance online publication, December 23, 2013; 10.1038/onc.2013.546 Abstract | Full Text |  |  |  | Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of BrafV600E::Pten–/– melanomaM Scortegagna, C Ruller, Y Feng, R Lazova, H Kluger, J-L Li, S K De, R Rickert, M Pellecchia, M Bosenberg and Z A Ronai Oncogene 2014 33: 4330-4339; advance online publication, September 16, 2013; 10.1038/onc.2013.383 Abstract | Full Text |  |  |  | The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation OPENJ Zhu, C Zhao, A Kharman-Biz, T Zhuang, P Jonsson, N Liang, C Williams, C-Y Lin, Y Qiao, K Zendehdel, S Strömblad, E Treuter and K Dahlman-Wright Oncogene 2014 33: 4340-4351; advance online publication, January 20, 2014; 10.1038/onc.2013.573 Abstract | Full Text |  | Short Communications | Top |  | Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complexF Wang, X Chen, C Li, Q Sun, Y Chen, Y Wang, H Peng, Z Liu, R Chen, K Liu, H Yan, B H Ye, D J Kwiatkowski and H Zhang Oncogene 2014 33: 4352-4358; advance online publication, September 30, 2013; 10.1038/onc.2013.401 Abstract | Full Text |  |  |  | Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells OPENV Barbetti, A Morandi, I Tusa, G Digiacomo, M Riverso, I Marzi, M G Cipolleschi, S Bessi, A Giannini, A Di Leo, P Dello Sbarba and E Rovida Oncogene 2014 33: 4359-4364; advance online publication, December 23, 2013; 10.1038/onc.2013.542 Abstract | Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | |
No comments:
Post a Comment